Approval · Notice of Compliance 24871 · 2020
EDECRIN: Notice of Compliance 24871
Issued December 22, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24871
- Date
- December 22, 2020
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EDECRIN | 02258528 | Marketed |
| SODIUM EDECRIN | 00268313 | Dormant |
Medicinal ingredients
- ETHACRYNIC ACID 25 MG per TAB
- ETHACRYNIC ACID 50 MG per VIAL